Target ALS and Alzheimer's Drug Discovery Foundation Announce Award Recipients for Biomarker Research

/PRNewswire/ -- Target ALS and the Alzheimer's Drug Discovery Foundation (ADDF) announced today the first four award recipients in a new initiative to identify...

Related Keywords

London ,City Of ,United Kingdom ,New York ,United States ,Chile ,American ,Ronalds Lauder ,Manuel Matamala Universidad ,Jessica Robin Winterlight ,Vanja Schneider ,Dan Doctoroff ,Howard Fillit ,Bill Gates ,Alejandro Bisquertt Zavala Neurognos ,Cruz Universidad ,Lou Gehrig ,Leonarda Lauder ,Mercedes Prudencio Mayo ,Niranjan Bose ,Agustin Iba ,Manish Raisinghani ,Leonard Petrucelli ,Pietro Fratta University College ,Pietro Fratta University College London ,Magdalini Polymenidou University Of Zurich ,Gianluigi Zanusso University Of Verona ,Giuseppe Legname Trieste International School For Advanced ,Andreas Hermann German Center ,Alzheimer Drug Discovery Foundation ,Innovative Partnership Funds Research ,Life Sciences At Gates Ventures ,Diagnostic Tools ,Drug Discovery Foundation ,Amyotrophic Lateral Sclerosis ,Frontotemporal Degeneration ,Founder Leonard ,Jessica Robin ,Winterlight Labs ,Andreas Hermann ,German Center ,Neurodegenerative Diseases ,Universidad Adolfo Iba ,Alejandro Bisquertt Zavala ,Manuel Matamala ,Universidad De Chile ,Andrea Slachevsky ,Rolando De La Cruz ,Gianluigi Zanusso ,Giuseppe Legname ,Trieste International School ,Advanced Studies ,University College ,Michael Ward ,Mercedes Prudencio ,Mayo Clinic ,Chief Science Officer ,Managing Director ,Life Sciences ,Diagnostics Accelerator ,Latin American ,University College London ,Real Time Quaking Induced Conversion ,New York City ,Alzheimer 39s Drug Discovery Foundation ,